Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
Goldman Sachs CEO David Solomon was awarded an $80 million stock bonus to stay at the helm for another five years, a stark turnaround for a leader whose survival was questioned after the firm's ...
Goldman Sachs reiterated its Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares with a steady price target of $78.00. The firm's analyst highlighted Ultragenyx's fourth-quarter total ...
Traditionally, ahead of most IPOs, teams of research analysts are invited to pore over the company’s financials and asked to publish recommendations ...
With a limited supply of sanctions-proof cargoes, discounts for Russian Urals crude to dated Brent have narrowed to ...
Goldman Sachs raised its 12-month price forecast for Europe's STOXX 600 index on Friday, citing factors such as lower risk ...
Peace should also help lift European equities, notes Barclays analysts. The UK bank’s basket of stocks that would benefit from Ukraine’s physical reconstruction has jumped again this week, and is now ...
The S&P 500 SPX initially fell as much as 1.1% after the hotter-than-forecast consumer price index report, but it didn't stay that way, with losses trimmed to 0.3% by the end of the session on ...
We recently published a list of 10 Worst Performing Bank Stocks in 2024. In this article, we are going to take a look at ...
Silver prices test key support at $31.81, with CPI data set to drive the next move. Will inflation push silver higher, or ...
Goldman Sachs increased its Bitcoin exposure in Q4 2024, boosting its holdings in Bitcoin exchange-traded funds (ETFs) by 88%, according to its latest SEC filing.